Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia Journal Article


Authors: Gray, J. R.; Wallner, K. E.
Article Title: Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia
Abstract: Twenty patients with leukemic (8) or lymphomatous (12) meningitis and cranial nerve palsies were treated with cranial irradiation at Memorial Sloan-Kettering Cancer Center from June 1987 through December 1988. The diagnosis of malignant meningitis was confirmed by malignant or `suspicious' cerebrospinal fluid cytology in 13 20 patients. The 6th and 7th cranial nerves were most commonly involved. Multiple nerve involvement was present in 11 20 patients, for a total of 42 nerves affected. Treatment consisted of whole brain irradiation to a median dose of 2400 cGy (range: 1000-3000) at 200-300 cGy per fraction. Median survival was 7 months. Forty of 42 nerves improved, for an actuarial response rate of 95% at 3 months. The complete response rate was 44% and was better for patients with lymphoma than for those with leukemia (72% vs 19%, p = 0.04). Delaying initiation of irradiation more than 3 days after the onset of symptoms did not affect the ultimate response rate, but slightly increased the median time to response (9 days vs 14 days, p = 0.1). Radiation therapy is an effective means of reversing cranial nerve dysfunction in leukemia and lymphoma. Higher doses may be needed to increase the rate of complete response. © 1990.
Keywords: adult; clinical article; aged; leukemia; conference paper; cytology; radiotherapy; relapse; central nervous system; meningeal neoplasms; lymphoma; irradiation; cranial nerve paralysis; paralysis; cranial nerve; middle age; cranial nerve diseases; human; male; female; priority journal
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 19
Issue: 2
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 1990-08-01
Start Page: 439
End Page: 444
Language: English
DOI: 10.1016/0360-3016(90)90555-x
PUBMED: 2394621
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kent E. Wallner
    48 Wallner